Skip to main content

Table 18 Autosampler stability results of amivantamab

From: Bioanalytical method development and validation for quantification of amivantamab in rat plasma by LC-MS/MS

Replicate no

HQC (75.0 ng/ml)

LQC (25.0 ng/ml)

MQC (50.0 ng/ml)

Concentration (ng/ml)

1

75.4

25.1

48.7

2

75.4

25.1

48.7

3

75.4

24.5

49.3

4

75.4

25.1

49.3

5

75.4

25.1

48.7

6

75.4

25.1

48.7

7

76.0

25.1

48.7

8

74.8

25.1

49.3

9

75.4

25.1

49.3

10

76.0

24.5

49.3

11

76.0

24.5

49.3

12

76.0

24.5

49.3

13

74.8

24.5

49.3

14

73.6

25.1

49.9

15

74.2

24.5

49.9

16

74.2

25.1

49.9

17

74.2

25.1

49.9

18

74.8

25.7

49.9

19

74.2

25.7

49.9

20

74.8

25.1

49.9

21

74.2

25.1

49.9

22

74.2

25.1

49.9

23

74.8

25.1

50.6

24

74.8

25.1

50.6

Mean

74.9

24.9

49.5

SD

0.7

0.4

0.6

% CV

0.9

1.4

1.1

% Mean accuracy

99.9%

99.9%

99.1%